Clinical record
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Müller B, Dürr S, Alonso S, et al. Zoonotic Mycobacterium bovis-induced tuberculosis in humans. Emerg Infect Dis 2013; 19: 898-908.
- 2. Department of Health. Zoonotic tuberculosis: on the decline. Canberra: Commonwealth of Australia; 2010. http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi3403m.htm (accessed July 2016).
- 3. Department of Agriculture and Fisheries. Bovine tuberculosis overview. Brisbane: Queensland Government; 2012. https://www.daf.qld.gov.au/animal-industries/animal-health-and-diseases/surveillance/tuberculosis (accessed July 2017).
- 4. Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis (Edinb) 2001; 81: 71-77.
- 5. Hannan MM, Desmond EP, Morlock GP, et al. Pyrazimamide-monoresistant Mycobacterium tuberculosis in the United States. J Clin Microbiol 2001; 39: 647-650.
- 6. Orlicka K, Barnes E, Culver EL. Prevention of infection caused by immunosuppressive drugs in gastroenterology. Ther Adv Chronic Dis 2013; 4: 167-185.
- 7. Australian Rheumatology Association. Screening for latent tuberculosis infection (LTBI) before use of biological agents in Australia. Sydney: ARA; 2010. https://rheumatology.org.au/downloads/April2010-FINAL-SCREENINGFORLATENTTUBERCULOSISINFECTION.pdf (accessed Feb 2016).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.